NCT03979625View on ClinicalTrials.gov

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Heparin-induced Thrombocytopenia
Interventions
OTHER

Hospitalization for more than 3 days with high clinical suspicion of HIT and positive anti-PF4/heparin antibodies

Patients are classified according to results of functional tests as having either Confirmed or Excluded HIT.

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT03979625 - Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation | Biotech Hunter | Biotech Hunter